What you are failing to grasp is that AI is only useful if it is trained properly. Australia has the highest number of these heart scans stored as images in a database and EIQ has the exclusive rights to use this data to training its AI engine giving it a unique value proposition that will be difficult for any other company to compete, call it a moat if you will.
In Australia, the National Echo Database Australia (NEDA) is a key resource for heart scan data, collecting measurements and reports from echocardiograms across the country to aid research into heart disease. Here's a more detailed breakdown: Key Features of NEDA: Data Collection: NEDA collects measurements and reports (but not images) from digital echo laboratories across Australia. Purpose: The data is used to understand heart measurements, health outcomes, and to compare against mortality data, allowing researchers to address important questions about heart disease. Scope: NEDA is designed to be the largest echo database in the world, encompassing a broad range of data from echocardiograms performed in Australia. Initial Analyses: The data will inform analyses focusing on pulmonary hypertension, aortic stenosis, and the role of artificial intelligence in diagnosing cardiac abnormalities. Data Sources: The Australian Heart Maps draw on data from AIHW National Hospital Morbidity Database, AIHW Mortality Over Regions and Time (MORT) books and risk factors.
EIQ Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)